Targeting licensed immune cells in cancer therapy: a new frontier for the future
Istituto di ricerca in biomedicina
Data: 29 Febbraio 2024 / 12:00 - 13:00
IRB Special Seminar
Prof. Domenico Mavilio
Principal Investigator, Head, Unit of Clinical and Experimental Immunology, Department of Medical Biotechnologies and Translational Medicine, Medical School of Milan University, Humanitas Research Hospital, Rozzano, Milan (IT)
Thursday, February 29, 2024
at 12:00 pm
Bios+ Seminar Room
Contact: Prof. Greta Guarda
